Zoledronic Acid Injection Mannitol-Water 5 mg Per 100 mL (0.05 mg per mL) Sterile Solution Single-Dose Bottle 100 mL (RX)

Zoledronic Acid Injection with Mannitol and Water is a sterile solution available in a single-dose bottle containing 5 mg of zoledronic acid per 100 mL, which equates to 0.05 mg per mL. This formulation is used as a bone resorption inhibitor, primarily indicated for the treatment and prevention of osteoporosis, management of Paget's disease of bone, and to reduce the risk of fractures in certain types of cancer that affect the bones. 

Key components include:

• Zoledronic Acid (5 mg per 100 mL): A bisphosphonate that inhibits osteoclast-mediated bone resorption, strengthening bones and reducing fracture risk.
  
• Mannitol: Often used as a stabilizer in the solution.
  
• Water for Injection: The solvent in which the active drug and other ingredients are dissolved.

This medication is administered intravenously and must be used under the guidance of a healthcare professional, with careful monitoring for potential side effects such as renal impairment, electrolyte imbalance, and rare but serious conditions like osteonecrosis of the jaw.

Indications:

• Osteoporosis: Helps to increase bone mineral density and reduce fractures in postmenopausal women and men.
  
• Paget's Disease of Bone: Normalizes abnormal bone turnover, promoting healthier bone formation.
  
• Bone Metastases: Reduces the risk of skeletal-related events such as fractures in cancer patients with metastatic bone disease.

Administration and Usage:

• Zoledronic Acid Injection should be administered intravenously by a healthcare professional. The infusion time typically lasts for at least 15 minutes. Proper pre-infusion hydration is recommended, and kidney function and serum calcium levels should be monitored before and after administration to minimize the risk of adverse effects such as renal impairment and hypocalcemia.

Storage:

Store the bottle at controlled room temperature, away from direct sunlight and moisture. Do not freeze. Ensure the product is used before its expiration date.

Warnings and Precautions:

• Monitor renal function and ensure patients are adequately hydrated prior to administration.
  
• Check serum calcium levels before and after infusion.
  
• Be cautious of potential side effects, including renal impairment, hypocalcemia, and rare conditions such as osteonecrosis of the jaw.
  
• Use with caution in patients with preexisting renal conditions or electrolyte imbalances.

Zoledronic Acid Injection by Meitheal Pharmaceuticals represents a critical therapeutic option for effectively managing severe bone conditions, contributing to improved patient quality of life through enhanced bone health and reduced risk of fractures.